Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|November 25, 2016
Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patientsClaudia M Hattinger, Serena Vella, Elisa Tavanti, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 21, 2016
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcomaClaudia Maria Hattinger, Elisa Tavanti, Marilù Fanelli, et al.
Expert Opinion on Emerging Drugs|May 30, 2015
Advances in emerging drugs for osteosarcomaClaudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, et al.
Plos One|November 30, 2016
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma CellsSerena Vella, Elisa Tavanti, Claudia Maria Hattinger, et al.
Current Cancer Drug Targets|November 10, 2015
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in OsteosarcomaMarilù Fanelli, Claudia Maria Hattinger, Serena Vella, et al.
Frontiers in Oncology|March 27, 2020
Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored TreatmentsMarilù Fanelli, Elisa Tavanti, Maria Pia Patrizio, et al.
Investigational New Drugs|September 7, 2014
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistanceValeria Sero, Elisa Tavanti, Serena Vella, et al.
Genes, Chromosomes & Cancer|December 24, 2008
Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell linesClaudia M Hattinger, Giuseppina Stoico, Francesca Michelacci, et al.
Cellular and Molecular Life Sciences : CMLS|November 16, 2018
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcomaIlaria Buondonno, Elena Gazzano, Elisa Tavanti, et al.
Analytical Cellular Pathology (Amsterdam)|June 16, 2011
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategyMichela Pasello, Maria Cristina Manara, Francesca Michelacci, et al.
Pageof 2